News
Congenital CMV linked to pediatric hyperdiploid ALL
- Author:
- M. Alexander Otto, PA, MMS
Publish date: January 18, 2023
Infection in some infants may alter immune function in a way that increases vulnerability to more direct causes of ALL.
News
Global effort needed to widen access to HSCT
- Author:
- M. Alexander Otto, PA, MMS
Publish date: December 10, 2022
Study findings reveal “unacceptably low” access to HSCT in some regions, triggering a call to action.
News
Managing trastuzumab deruxtecan adverse events in the real world
- Author:
- M. Alexander Otto, PA, MMS
Publish date: December 1, 2022
Doctor says real-world toxicity experience has been worse than clinical trial data.
News
FDA OKs teclistamab for relapsed/refractory multiple myeloma
- Author:
- M. Alexander Otto, PA, MMS
Publish date: October 25, 2022
FDA has approved teclistamab as a new treatment option for heavily pretreated adults with relapsed/refractory multiple myeloma.
News
Vaginal estrogen not recommended with aromatase inhibitors
- Author:
- M. Alexander Otto, PA, MMS
Publish date: October 24, 2022
“Patients who are taking aromatase inhibitors should try alternative strategies for management of genitourinary symptoms.”
News
FDA approved acalabrutinib tablet for MCL, CLL, SLL
- Author:
- M. Alexander Otto, PA, MMS
Publish date: October 19, 2022
Acalabrutinib (Calquence) in tablet formulation approved by FDA.
News
At-home test for oral/throat cancer launched in U.S.
- Author:
- M. Alexander Otto, PA, MMS
Publish date: August 30, 2022
It is not covered by medical insurance, and is not approved by the Food and Drug Administration.